Search Results - "Chirovsky, Diana"

Network meta-analysis of pembrolizumab as monotherapy and in combination with chemotherapy for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma.

Alternate Title: Metanálise em rede comparativa de pembrolizumabe como monoterapia e em combinação com quimioterapia para tratamento de primeira linha de carcinoma de células escamosas da cabeça e pescoço recorrente ou metastático.

Authors: Mojebi, Ali Ramakrishnan, Karthik Ayers, Dieter et al.

Source: JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde. abr2024, Vol. 16 Issue 1, p25-64. 40p.

Subjects: SQUAMOUS cell carcinoma, COMBINATION drug therapy, PEMBROLIZUMAB, BAYESIAN analysis, OVERALL survival

Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.

Authors: Hughes, Brett G. M. Mendoza, Rene Gonzalez Basset-Seguin, Nicole et al.

Source: Dermatology & Therapy. Oct2021, Vol. 11 Issue 5, p1777-1790. 14p.

First-line treatment patterns and outcomes in advanced non-small cell lung cancer in Sweden: a population-based real-world study with focus on immunotherapy.

Authors: Wagenius, Gunnar Vikström, Anders Berglund, Anders et al.

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p198-205. 8p.

Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.

Authors: Hirji, Ishan Gupta, Shaloo Goren, Amir et al.

Source: Health & Quality of Life Outcomes. 2013, Vol. 11 Issue 1, p1-11. 11p. 2 Diagrams, 3 Charts.